Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory.
Steinberg
D A
DA
IntraBiotics Pharmaceuticals, Inc., Sunnyvale, CA, USA.
Lehrer
R I
RI
D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides; D001681:Biological Assay; D003470:Culture Media; D004268:DNA-Binding Proteins / Q000032:analysis / Q000494:pharmacology; D004058:Diffusion; D004591:Electrophoresis, Polyacrylamide Gel; D004926:Escherichia coli / Q000254:growth & development; D007700:Kinetics; D009391:Nephelometry and Turbidimetry; D010455:Peptides / Q000032:analysis* / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000032:analysis / Q000494:pharmacology; D011112:Polymyxin B / Q000032:analysis / Q000494:pharmacology; D011479:Protamines / Q000032:analysis / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D003470:Culture Media; D004268:DNA-Binding Proteins; D010455:Peptides; D010456:Peptides, Cyclic; D011479:Protamines; C057636:tachyplesin peptide, Tachypleus tridentatus; D011112:Polymyxin B